C Charles Jain1, Darrell B Newman1, Jeffrey B Geske2. 1. Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA. 2. Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA. Geske.Jeffrey@mayo.edu.
Abstract
PURPOSE OF REVIEW: To discuss the critical role of the mitral valve (MV) in the pathophysiology of obstruction in hypertrophic cardiomyopathy (HCM), evaluation of the MV in HCM, the impact of MV characteristics on treatment in HCM, and management of the MV at the time of septal myectomy. RECENT FINDINGS: Multimodality imaging helps describe mitral abnormalities in HCM, though significant controversy persists on what to do with these abnormalities. In certain cases, intervention on the MV may be necessary, although outcomes may be worse in those who undergo mitral interventions. Thorough assessment of MV anatomy and function is paramount in evaluating a patient with HCM. Emphasis should be placed on thorough evaluation and description of mitral abnormalities in HCM. Given significant practice variation, future studies could compare MV practice differences across institutions and how these impact long-term outcomes.
PURPOSE OF REVIEW: To discuss the critical role of the mitral valve (MV) in the pathophysiology of obstruction in hypertrophic cardiomyopathy (HCM), evaluation of the MV in HCM, the impact of MV characteristics on treatment in HCM, and management of the MV at the time of septal myectomy. RECENT FINDINGS: Multimodality imaging helps describe mitral abnormalities in HCM, though significant controversy persists on what to do with these abnormalities. In certain cases, intervention on the MV may be necessary, although outcomes may be worse in those who undergo mitral interventions. Thorough assessment of MV anatomy and function is paramount in evaluating a patient with HCM. Emphasis should be placed on thorough evaluation and description of mitral abnormalities in HCM. Given significant practice variation, future studies could compare MV practice differences across institutions and how these impact long-term outcomes.
Authors: P Boekstegers; J Hausleiter; S Baldus; R S von Bardeleben; H Beucher; C Butter; O Franzen; R Hoffmann; H Ince; K H Kuck; V Rudolph; U Schäfer; W Schillinger; N Wunderlich Journal: Clin Res Cardiol Date: 2014-02 Impact factor: 5.460
Authors: Barry J Maron; Joseph A Dearani; Steve R Ommen; Martin S Maron; Hartzell V Schaff; Bernard J Gersh; Rick A Nishimura Journal: J Am Coll Cardiol Date: 2004-11-16 Impact factor: 24.094
Authors: Jacobo Moreno Garijo; Cristina Ibáñez; Juan M Perdomo; Martin D Abel; Massimiliano Meineri Journal: Asian Cardiovasc Thorac Ann Date: 2021-09-24